INBX compared with MGTX: revenue, margins and what each company keeps, and the suppliers and customers both name

INBXInhibrx Biosciences, Inc.

Mkt capRevenueRevenue

MGTXMeiraGTx Holdings plc

Mkt capRevenueRevenue

Compare

INBXInhibrx Biosciences, Inc.

MGTXMeiraGTx Holdings plc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

INBX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.9%▼−8.91%×0.75

May 15 '26±7.1%▼−6.47%×0.92

Q1 FY26±6.5%▼−6.09%×0.94

Q3 FY25±18.3%▲+6.04%×0.33

MGTX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±34.0%▼−2.24%×0.06

May 14 '26±23.0%▼−0.20%×0.01

= impliedINBX realized, solidMGTX realized, hatchedOne scale, both sides: full bar = 49%× = |realized| ÷ impliedSource: market data

Q1 FY26

±48.4%

▼−1.18%

×0.02

Q3 FY25±39.0%▼−4.62%×0.12

INBXInhibrx Biosciences, Inc.

71.78▼−0.01%· post 72.24· delayed

Mkt cap$1.1BRevenue$1MQ2 FY25Revenue—

MGTXMeiraGTx Holdings plc

9.45▼−0.44%· post 9.32· delayed

After hoursNov 2 '26delayed

Mkt cap$911.4MRevenue$321MQ2 FY26Revenue$81MFY25

Compare

After hoursNov 2 '26delayed

INBXInhibrx Biosciences, Inc.

MGTXMeiraGTx Holdings plc

71.78▼−0.01%post 72.24delayed

Price

9.45▼−0.44%post 9.32delayed

$1.1B

Mkt cap

$911.4M

Q2 FY25$1M

Revenue

$321MQ2 FY26

—

Revenue

$81MFY25

INBX71.78▼−0.01%vsMGTX9.45▼−0.44%After hoursNov 2 '26delayed